Geographic, Health-System and Socioeconomic Drivers of MDR-TB Burden in District Mandi, Himachal Pradesh
Insights for Achieving India’s End TB 2030 Targets
Keywords:
DR-TB, characteristics patients, Delay, Geographic LocationsAbstract
Background: Multidrug-resistant tuberculosis (MDR-TB) remains a critical public health challenge in India, despite notable declines in TB incidence and mortality under the National Tuberculosis Elimination Programme (NTEP). Mountainous districts such as Mandi in Himachal Pradesh face amplified barriers to timely diagnosis and treatment. This study analyzes block-wise MDR-TB characteristics to identify diagnostic delays, treatment gaps, resistance patterns and socioeconomic factors shaping outcomes.
Methods: A retrospective observational analysis was conducted using secondary data from all 28 Designated Microscopy Centres (DMCs) in District Mandi during 2018–19. Data on institutional inputs, diagnostic infrastructure, sputum testing, drug-resistance profiles, treatment initiation timelines, geographic accessibility, clinical complaints, and sociodemographic variables were analysed descriptively across blocks.
Results: The district reported 919 sputum-positive TB cases and notable gaps in laboratory capacity, with only 35.7% of DMCs equipped with LED microscopes. Mean distance to the nearest CBNAAT facility was 50.75 km, reaching 150 km in remote blocks. Primary MDR-TB accounted for 11–100% of cases, and XDR-TB was concentrated in Bagsiad (36.4%). Diagnostic delays >7 days ranged from 22.2% to 78.6%, particularly high in Ratti. Treatment initiation within 7 days varied widely (12.5–87.5%). Significant socioeconomic vulnerabilities were observed, including unemployment post-diagnosis (up to 75%), overcrowding (20–57.1%), and presence of concurrent TB cases within families and communities. Patients often travelled >100 km for diagnosis and specialist care, prioritizing perceived quality over proximity.
Conclusion: MDR-TB control in Mandi district is challenged by geographic inaccessibility, limited diagnostic capacity, socioeconomic distress and substantial block-level disparities. Strengthening decentralised molecular diagnostics, ensuring rapid treatment initiation, improving transport and social support, and targeting high-burden blocks are critical for aligning district performance with India’s End TB goal.
Downloads
References
Central TB Division. India TB Report 2024: National TB Elimination Programme. New Delhi: Ministry of Health and Family Welfare, Government of India; 2024.
Dorjee K, Sadutshang TD, Rana RS, Topgyal S, Phunkyi D, Choetso T, Chodon T, Parmar M, Singla R, Paster Z, Chaisson RE, Kaushal KC. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India. Indian J Tuberc. 2020;67(1):59-64.
Thakur S, Chauhan V, Thakur P, Kumar R, Beri G. From diagnosis to treatment: Streamlining TB care pathways in the hilly terrains of Shimla district. Indian J Med Res. 2025 Aug;162(2):169-174.
Ladha N, Kikkeri Hanumantha Setty N, Bhardwaj P (October 05, 2025) Factors Affecting Treatment Adherence Among Persons With Multidrug-Resistant Tuberculosis (MDR-TB) in Western India: A Qualitative Exploration. Cureus 17(10): e93906.
Yasobant S, Shah H, Bhavsar P, Patel J, Saha S, Sinha A, et al. Why and where?—Delay in Tuberculosis care cascade: A cross sectional assessment in two Indian states, Jharkhand, Gujarat. Public Health. 2023; 11: 1015024
Balasubramnian A, Francis PT, Leelamoni K, Rakesh PS, Lalu JS. Diagnostic and treatment delay among new pulmonary tuberculosis patients in Southern India: A cross-sectional study. Indian J Public Health 2022;66:S60 5
Akalu, T.Y., Clements, A.C.A., Gebreyohannes, E.A. et al. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China. BMC Infect Dis 2024; 24, 159.
Atre S, Jagtap J, Faqih M, Dumbare Y, Sawant T, Ambike S, et al. Addressing patients’ unmet needs related to multidrug resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India. PLoS ONE. 2023; 18(12): e0295508
Shewade HD, Govindarajan S, Sharath BN, Tripathy JP, Chinnakali P, Kumar AM, Muthaiah M, Vivekananda K, Paulraj AK, Roy G. MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why? Public Health Action. 2015;5(2):132-9
Bendle, S. S. and Goyal, R. C. “Delay in initiating MDR contacts of MDR-TB cases in Wardha district, Maharashtra, India. International Journal of Current Research. 2017; 9, (12): 63327-9
Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019-25.
Belkina TV, Khojiev DS, Tillyashaykhov MN, Tigay ZN, Kudenov MU, Tebbens JD, Vlcek J. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study. BMC Infectious Diseases 2014 14:624
Oga-Omenka C, Sassi A, Aguilera Vasquez N, Rana N, Essar MY, Ku D, Diploma H, Huria L, Saqib K, Das R, Stallworthy G, Pai M. A methodological review of patient healthcare-seeking journeys from symptom onset to receipt of care. BMJ Glob Health. 2025 May 16;10(5):e016978.
E.P. Mseke, B. Jessup, T. Barnett. Impact of distance and/or travel time on healthcare service access in rural and remote areas: A scoping review. Journal of Transport & Health. 2024; 37: 101819
Ram B, Thakur R. Epidemiology and Economic Burden of Continuing Challenge of Infectious Diseases in India: Analysis of Socio-Demographic Differentials. Front Public Health. 2022;10:901276. doi: 10.3389/fpubh.2022.901276.
Chipeta M G, Kumaran EPA, Browne AJ, Hamadani BHK, Woodhouse GH, Sartorius B. Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study. The Lancet Planetary Health. 2022; 6 (8): e670 - e681
Aldridge RW, Pineo H, Fragaszy E, Eyre MT, Kovar J, Nguyen V, et al. Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and Wales. Wellcome Open Res. 2021 ;6:347.
Skinner D, Claassens M. It's complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infect Dis. 2016;16(1):712.
Singh AR, Pakhare A, Kokane AM, Shewade HD, Chauhan A, Singh A, et al. ‘Before reaching the last mile’- Knowledge, attitude, practice and perceived barriers related to tuberculosis directly observed therapy among ASHA workers in Central India: A mixed method study. Journal of Epidemiology and Global Health. 2017; 7 (4): 219-225
Zhao Q, Wang L, Tao T, Xu B. Impacts of the "transport subsidy initiative on poor TB patients" in Rural China: a patient-cohort based longitudinal study in rural China. PLoS One. 2013 Nov 25;8(11):e82503.
Jhaveri TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, Voehler D, Chung M, et al. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies. PLoS Med. 2024 May 28;21(5):e1004409.
Yasobant S, Bhavsar P, Kalpana P, Memon F, Trivedi P, Saxena D. Contributing Factors in the Tuberculosis Care Cascade in India: A Systematic Literature Review. Risk Manag Healthc Policy. 2021;14:3275-3286
Merid MW, Muluneh AG, Yenit MK, Kassa GM (2020) Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010–2017. PLoS ONE 15(10): e0240564.
Natarajan S, Singla R, Singla N, Gupta A, Caminero JA, Chakraborty A, et al. Treatment interruption patterns and adverse events among patients on bedaquiline containing regimen under programmatic conditions in India. Pulmonology. 2022; 28(3): 203-209.
Tola, H.H., Holakouie-Naieni, K., Mansournia, M.A. et al. Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia. Sci Rep. 2019; 9: 20030
Published
How to Cite
License
Copyright (c) 2026 DR AKSHAY MINHAS, DR MITASHA SINGH, DR SHWETA GOSWAMI, DR NARESH JEENGAR
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
